Skip to main content

Table 1 Characteristics of preclinical rheumatoid arthritis cases and matched controls at time of blood collection in the Nurses’ Health Study and Nurses’ Health Study II a

From: Anti-citrullinated peptide autoantibodies, human leukocyte antigen shared epitope and risk of future rheumatoid arthritis: a nested case–control study

Characteristics

RA cases (N = 192)

Matched controls (N = 567)

Cohort, n (%)

  

  NHS

136 (70.8)

405 (71.4)

  NHSII

56 (29.2)

162 (28.6)

Caucasian, n (%)

190 (99.0)

556 (98.1)

Mean age at blood collection, years (SD)

52.3 (8.0)

52.4 (8.1)

Never smoker, n (%)

83 (43.2)

279 (49.2)

Current smoker, n (%)

33 (17.2)

82 (14.5)

Past smoker, n (%)

76 (39.6)

206 (36.3)

Mean pack-years of smokingb (SD)

23.1 (16.4)

20.8 (18.8)

Mean alcohol intake, g/day (SD)

4.2 (5.6)

5.7 (8.9)

Mean BMI, kg/m2 (SD)

26.1 (5.0)

25.0 (4.4)

Premenopausal, n (%)

65 (33.9)

193 (34.0)

Parous, n (%)

175 (91.1)

511 (90.1)

Irregular menses, n (%)

32 (16.7)

56 (9.9)

Positive for any ACPA, n (%)

48 (25.0)

38 (6.7)

Positive for anti-CCP, n (%)

23 (12.0)

0 (0)

Mean age at RA diagnosis, years (SD)

59.9 (9.9)

 

Mean time to RA onset, months (SD)

91.1 (53.6)

 

Median time to RA onset, months (IQR)

87.5 (92.0)

 

Morning stiffness, n (%)

143 (74.5)

 

Arthritis three or more joint areas, n (%)

176 (91.7)

 

Hand arthritis, n (%)

191 (99.5)

 

Symmetric arthritis, n (%)

188 (97.9)

 

Nodules, n (%)

21 (10.9)

 

Erosions, n (%)

43 (22.4)

 
  1. aACPA: anticitrullinated peptide autoantibody, BMI: body mass index, CCP: cyclic citrullinated peptide, NHS: Nurses’ Health Study, NHSII: Nurses’ Health Study II, RA: rheumatoid arthritis. bPack-years among ever smokers only.